x

Posted 03 December, 2021

Envista Holdings Corp appointed new CEO

CEO Change detected for ticker NYSE:NVST in a 8-K filed on 03 December, 2021.


  On November 30, 2021, the board of directors (the "Board") of Envista Holdings Corporation ("Envista") appointed Barbara B. Hulit, Senior Vice President of Fortive Corporation ("Fortive") and President and CEO of Fortive's Advanced Healthcare Solutions, as a Class I director of Envista and as a member of the Audit Committee of the Board, effective December 1, 2021.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Envista Holdings Corp
Health Care/Life Sciences • Medical Equipment/Supplies
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.
Market Cap
$3.64B
View Company Details
Envista Holdings Corp by TradingView
Relevant filing section
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENT OF CERTAIN OFFICERS


On November 30, 2021, the board of directors (the "Board") of Envista Holdings Corporation ("Envista") appointed Barbara B. Hulit, Senior Vice President of Fortive Corporation ("Fortive") and President and CEO of Fortive's Advanced Healthcare Solutions, as a Class I director of Envista and as a member of the Audit Committee of the Board, effective December 1, 2021. In connection with such appointment, the Board determined that Ms. Hulit is independent within the meaning of the listing standards of the New York Stock Exchange and also meets the standards of director independence for audit committee members set forth in Rule 10A-3 of the General Rules and Regulations under the Securities Exchange Act of 1934, as amended. 


In connection with Ms. Hulit's appointment to the Board, and consistent with the Board's current compensation arrangements for non-employee directors as described in Envista's Definitive Proxy Statement for its 2021 Annual Meeting of Stockholders, as filed with the Securities and Exchange Commission (the "Commission") on April 12, 2021, Ms. Hulit will be eligible to receive the Company's standard annual retainer, pro-rated for the remainder of the Company's 2021 fiscal year. Ms. Hulit also will be eligible to receive equity awards as part of the Company's standard compensation for non-employee directors, as well as reimbursement of expenses.


Ms. Hulit has also entered into an indemnification agreement with Envista, the form of which was filed as Exhibit 10.20 to Envista's Registration Statement on Form S-1 (File No. 333-232758) filed with the Commission on July 22, 2019 and which is incorporated herein by reference.


There is no arrangement or understanding between Ms. Hulit and any other person pursuant to which she was selected as a director of Envista. There are no transactions in which Ms. Hulit has an interest requiring disclosure under Item 404(a) of Regulation S-K.